References
- AlvarezWC. Notes on the history of migraine. Headache2, 209–213 (1963).
- PearceJMS. Historical aspects of migraine. J. Neurol. Neurosurg. Psychiatry49, 1097–1103 (1986).
- VosT, FlaxmanAD, NaghaviMet al.Year lived with disability (YLDs) for 110 sequelae of 289 diseases and injuries: a systematic analysis for the global burden of disease study. Lancet380(989), 2163–2196 (2010).
- LeonardiM, RaggiA. Burden of migraine: international perspectives. Neurol. Sci.34(Suppl. 1), S117–S118 (2013).
- GaspariniCF, SmithRA, GriffithsLR. Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J. Headache Pain18, 20 (2017).
- CozzolinoO, MarcheseM, TrovatoFet al.Understanding spreading depression from headache to sudden unexpected death. Front. Neurol.9, 19 (2018).
- RavalAD, ShahA. National trends in direct health care expenditures among US adults with migraine: 2004 to 2013. J. Pain18, 96–107 (2017).
- FordJH, JacksonJ, MilliganGet al.A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns. Headache57(10), 1532–1544 (2017).
- SutherlandHG, GriffithsLR. Genetics of migraine: insights into the molecular basis of migraine disorders. Headache57(4), 537–569 (2017).
- GuptaVK. CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev. Neurother.9(11), 1595–614 (2009).
- GuptaVK. Adaptive Mechanisms in Migraine. A Comprehensive Synthesis In Evolution. Breaking the Migraine Code. Nova Science Publishers, NY, USA (2009).
- GuptaVK. Patent foramen ovale closure and migraine: science and sensibility. Expert Rev. Neurother.10(9), 1409–1422 (2010).
- HougaardA, AminFM, ChristensenCEet al.Increased brainstem perfusion, but no blood–brain barrier disruption, during attacks of migraine with aura. Brain140(6), 1633–1642 (2017).
- CharlesA. The pathophysiology of migraine: implications for clinical management. Lancet Neurol.17(2), 174–182 (2018).
- DodickDW. Migraine. Lancet391(10127), 1315–1330 (2018).
- StensrudP, SjaastadO. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache20(4), 204–207 (1980).
- ForssmanB, LindbladCJ, ZbornikovaV. Atenolol for migraine prophylaxis. Headache23(4), 188–190 (1983).
- JohannssonV, NilssonLR, WideliusTet al.Atenolol in migraine prophylaxis: a double-blind cross-over multicentre study. Headache27(7), 372–374 (1987).
- RyanRESr, RyanREJr, SudilovskyA. Nadolol: its use in the prophylactic treatment of migraine. Headache23(1), 26–31 (1983).
- BonusoS, MaranoE, di StasioEet al.Source of pain and primitive dysfunction in migraine: an identical site?J. Neurol. Neurosurg. Psychiatry.52(12), 1351–1354 (1989).
- GuptaVK. A clinical review of the adaptive potential of vasopressin in migraine. Cephalalgia17(5), 561–569 (1997).
- LeãoAAP. Spreading depression of activity in cerebral cortex. J. Neurophysiol.7, 359–390 (1944).
- LashleyKS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch. Neurol. Psychiatry.46, 331–339 (1941).
- MilnerPM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. Electroencephalogr. Clin. Neurophysiol. (Suppl 10), 10, 705 (1958).
- HartingsJA, ShuttleworthCW, KirovSAet al.The continuum of spreading depolarizations in acute cortical lesion development: examining Leão’s legacy. J. Cereb. Blood Flow Metab.37, 1571–1594 (2017).
- MayA. Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging. Neurol. Sci.38(Suppl 1), 125–130 (2017).
- GoadsbyPJ, HollandPR, Martins-OliveiraMet al.Pathophysiology of migraine: a disorder of sensory processing. Physiol. Rev.97, 533–622 (2017).
- Editorial. On the falsification of ideas. Lancet340, 344–345 (1992).
- YanJ, DussorG. Ion channels and migraine. Headache.54(4), 619–639 (2014).
- RabkinR, StablesDP, LevinNWet al.The prophylactic value of propranolol in angina pectoris. Am. J. Cardiol.18, 370–383 (1966).
- WeerasuriyaK, PatelL, TurnerP. β-adrenoceptor blockade and migraine. Cephalalgia2, 334–345 (1982).
- WelchKMA. Migraine. A biobehavioral disorder. Arch. Neurol.44, 323–327 (1987).
- GuptaVK. Reader response: “Migraine with visual aura is a risk factor for incident atrial fibrillation: a cohort study”. Neurology (2018). http://n.neurology.org/content/reader-response-migraine-visual-aura-risk-factor-incident-atrial-fibrillation)
- GuptaVK. Noninvasive vagal nerve stimulation: a new dimension of empiricism. Neurology (2018). http://n.neurology.org/content/noninvasive-vagal-nerve-stimulation-new-dimension-empiricism
- GuptaVK. Calcitonin-gene related peptide antagonism to prevent migraine: hope, hype, and hokum. Neurology (2017). http://n.neurology.org/content/89/12/1237.long#comments
- TasorelliC, DeIcco R. Getting closer to a cure for migraine. Nat. Rev. Neurol.doi:10.1038/s41582-019-0134-z (2019) (Epub ahead of print).
- BorgdorffP. Arguments against the role of cortical spreading depression in migraine. Neurol. Res.40, 173–181 (2018).
- HuppSL, KlineLB, CorbettJJ. Visual disturbances in migraine. Surv. Ophthalmol.33, 221–236 (1989).
- PeatfieldRC, RoseFC. Migrainous visual symptoms in a woman without eyes. Arch. Neurol.38, 466 (1981).
- NicolodiM, FrezzottiR, DiadoriAet al.Phantom eye: features and prevalence. The predisposing role of headache. Cephalalgia17, 501–504 (1997).
- SörösP, VoO, HusstedtI-Wet al.Phantom eye syndrome. Its prevalence, phenomenology, and putative mechanisms. Neurology60, 1542–1543 (2003).
- NosedaR, KainzV, JakubowskiMet al. . A neural mechanism for exacerbation of headache by light. Nat. Neurosci.13, 239–245 (2010).
- SilvaGCC, GóesCPQF, VincentMB. Aura-like features and photophobia in sightless migraine patients. Arq. Neuropsiquiatr.72, 949–963 (2014).
- GuptaVK. Migrainous scintillating scotoma and headache is ocular in origin: a new hypothesis. Med. Hypotheses66, 454–460 (2006).